97 related articles for article (PubMed ID: 3250032)
1. Concentrations of sex-hormone-binding-globulin (SHBG) in a population of normal women: relationship to risk factors for breast cancer.
Moore JW; Key TJ; Clark GM; Bulbrook RD; Allen DS; Wang DY; Pike MC
Steroids; 1988 Oct; 52(4):391-2. PubMed ID: 3250032
[No Abstract] [Full Text] [Related]
2. Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.
Moore JW; Key TJ; Bulbrook RD; Clark GM; Allen DS; Wang DY; Pike MC
Br J Cancer; 1987 Nov; 56(5):661-6. PubMed ID: 3426933
[TBL] [Abstract][Full Text] [Related]
3. Sex-hormone-binding globulin and breast cancer risk.
Moore JW; Key TJ; Clark GM; Hoare SA; Allen DS; Wang DY
Anticancer Res; 1987; 7(5B):1039-47. PubMed ID: 3324935
[TBL] [Abstract][Full Text] [Related]
4. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
5. [Competitive binding assay with dextran-coated charcoal for measurement of sex hormone-binding globulin in breast cancer].
Suminaga Y; Sonoo H; Morimoto T
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):341-9. PubMed ID: 2423861
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status.
Sulkes A; Fuks Z; Gordon A; Gross J
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):19-23. PubMed ID: 6537912
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
8. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients.
Murayama Y
Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084
[TBL] [Abstract][Full Text] [Related]
9. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
Bruning PF; Bonfrèr JM; Hart AA
Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
[TBL] [Abstract][Full Text] [Related]
10. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study.
Bruning PF; Bonfrèr JM; Hart AA; van Noord PA; van der Hoeven H; Collette HJ; Battermann JJ; de Jong-Bakker M; Nooijen WJ; de Waard F
Int J Cancer; 1992 Apr; 51(1):14-9. PubMed ID: 1563834
[TBL] [Abstract][Full Text] [Related]
11. Determinants of prolactin in postmenopausal Chinese women in Singapore.
Katz TA; Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Oesterreich S; Butler LM
Cancer Causes Control; 2018 Jan; 29(1):51-62. PubMed ID: 29124543
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls.
Adami HO; Johansson ED; Vegelius J; Victor A
Ups J Med Sci; 1979; 84(3):259-74. PubMed ID: 575585
[TBL] [Abstract][Full Text] [Related]
13. Relationship between sex hormone binding globulin and estrogen receptors in breast cancer.
Plymate SR; Stutz FH; Fariss BL
J Clin Oncol; 1984 Jun; 2(6):652-4. PubMed ID: 6539364
[TBL] [Abstract][Full Text] [Related]
14. Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors.
Nagata C; Shimizu H; Takami R; Hayashi M; Takeda N; Yasuda K
Jpn J Cancer Res; 2000 Sep; 91(9):948-53. PubMed ID: 11011124
[TBL] [Abstract][Full Text] [Related]
15. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen binding and risk factors for breast cancer.
Ingram DM; Nottage EM; Willcox DL; Roberts A
Br J Cancer; 1990 Feb; 61(2):303-7. PubMed ID: 2310682
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
18. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer.
Adlercreutz H; Hämäläinen E; Gorbach SL; Goldin BR; Woods MN; Dwyer JT
Am J Clin Nutr; 1989 Mar; 49(3):433-42. PubMed ID: 2923075
[TBL] [Abstract][Full Text] [Related]
19. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
Murayama Y
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
[No Abstract] [Full Text] [Related]
20. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H
J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
